244 related articles for article (PubMed ID: 27931265)
1. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment.
Foveau B; Albrecht S; Bennett DA; Correa JA; LeBlanc AC
Acta Neuropathol Commun; 2016 Dec; 4(1):127. PubMed ID: 27931265
[TBL] [Abstract][Full Text] [Related]
2. Caspase-6 activity predicts lower episodic memory ability in aged individuals.
Ramcharitar J; Afonso VM; Albrecht S; Bennett DA; LeBlanc AC
Neurobiol Aging; 2013 Jul; 34(7):1815-24. PubMed ID: 23402898
[TBL] [Abstract][Full Text] [Related]
3. Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits.
Noël A; Foveau B; LeBlanc AC
Cell Death Dis; 2021 Mar; 12(3):227. PubMed ID: 33649324
[TBL] [Abstract][Full Text] [Related]
4. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease.
Ramcharitar J; Albrecht S; Afonso VM; Kaushal V; Bennett DA; Leblanc AC
J Neuropathol Exp Neurol; 2013 Sep; 72(9):824-32. PubMed ID: 23965742
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
7. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.
Giannakopoulos P; Herrmann FR; Bussière T; Bouras C; Kövari E; Perl DP; Morrison JH; Gold G; Hof PR
Neurology; 2003 May; 60(9):1495-500. PubMed ID: 12743238
[TBL] [Abstract][Full Text] [Related]
8. The unfolded protein response is activated in the olfactory system in Alzheimer's disease.
Murray HC; Dieriks BV; Swanson MEV; Anekal PV; Turner C; Faull RLM; Belluscio L; Koretsky A; Curtis MA
Acta Neuropathol Commun; 2020 Jul; 8(1):109. PubMed ID: 32665027
[TBL] [Abstract][Full Text] [Related]
9. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation.
Kaushal V; Dye R; Pakavathkumar P; Foveau B; Flores J; Hyman B; Ghetti B; Koller BH; LeBlanc AC
Cell Death Differ; 2015 Oct; 22(10):1676-86. PubMed ID: 25744023
[TBL] [Abstract][Full Text] [Related]
10. Caspase-6 as a novel early target in the treatment of Alzheimer's disease.
LeBlanc AC
Eur J Neurosci; 2013 Jun; 37(12):2005-18. PubMed ID: 23773070
[TBL] [Abstract][Full Text] [Related]
11. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia.
Buchman AS; Leurgans SE; Kim N; Agrawal S; Oveisgharan S; Zammit AR; VanderHorst V; Nag S; Bennett DA
J Alzheimers Dis; 2023; 96(2):563-578. PubMed ID: 37840485
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment.
Flores J; Noël A; Fillion ML; LeBlanc AC
Cell Death Differ; 2022 Mar; 29(3):657-669. PubMed ID: 34625662
[TBL] [Abstract][Full Text] [Related]
15. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
16. Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.
Sivananthan SN; Lee AW; Goodyer CG; LeBlanc AC
Cell Death Dis; 2010 Nov; 1(11):e100. PubMed ID: 21368865
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
18. Early Alzheimer-type lesions in cognitively normal subjects.
Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
[TBL] [Abstract][Full Text] [Related]
19. Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.
Tremblay C; Serrano GE; Intorcia AJ; Mariner MR; Sue LI; Arce RA; Atri A; Adler CH; Belden CM; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
J Neuropathol Exp Neurol; 2022 Jul; 81(8):643-649. PubMed ID: 35751438
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
